A retrospective analysis on first-line bevacizumab, cetuximab, and panitimumab-containing regimens in patients with RAS-wild metastatic colorectal cancer: A Collaborative Study by Turkish Oncology Group (TOG).

DEGIRMENCIOGLU S., TANRIVERDI O., MENEKSE S., DOGAN M., HACıOGLU B., OKTAY E., ...Daha Fazla

Journal of B.U.ON. : official journal of the Balkan Union of Oncology, cilt.24, ss.136-142, 2019 (SCI-Expanded) identifier identifier